UM  > 中華醫藥研究院
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects
Tianhong Yin1; Xiangjun Kong2; Yitao Wang2; Xin Chen2; Yuanjia Hu2; Rong Shao1
Source PublicationInnovation Value Chain of Chinese Pharmaceuticals
Author of SourceYitao Wang, Yuanjia Hu, Albert Wai-Kit Chan
Publication PlaceWhitestone, New York
PublisherUnited States-China Intellectual Property Institute Inc.

Monoclonal Antibodies (mAbs) have become a major class of biopharmaceutics for the treatment of major human diseases including cancers and autoimmune diseases. Consequently, the market for mAbs is the fastest-growing sector of the biopharmaceutical industry. Cross-institutional and cross-country collaboration is increasingly important in the R&D (research and development) of therapeutic mAbs. We analyzed collaboration patterns by capturing collaborative relationships in mAb R&D. To this end, the network analysis, a promising method for defining and assessing complex collaborative relationships as shown previously by other investigators, has been employed. More specifically, our study aims 1) to visualize the overall institutional collaboration network; 2) to identify the key firms and the behavioral characteristics expressed in the network; 3) to investigate special collaboration patterns among the firms in the network; and 4) to detect the evolving patterns of R&D collaboration from a country-based perspective and understand the changing positions of specific countries throughout the development period. The results of our analysis may help the stakeholders of mAb R&D to make decisions in seeking collaboration partners.

KeywordMonoclonal Antibodies Research And Development Network Analysis Institutional Collaboration Network Country-based Collaboration Network
Fulltext Access
Document TypeBook chapter
CollectionInstitute of Chinese Medical Sciences
Affiliation1.School of International Pharmaceutical Business, China Pharmaceutical University, Jiangsu, China
2.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China
Recommended Citation
GB/T 7714
Tianhong Yin,Xiangjun Kong,Yitao Wang,et al. Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects. Whitestone, New York:United States-China Intellectual Property Institute Inc.,2017:135-158.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Tianhong Yin]'s Articles
[Xiangjun Kong]'s Articles
[Yitao Wang]'s Articles
Baidu academic
Similar articles in Baidu academic
[Tianhong Yin]'s Articles
[Xiangjun Kong]'s Articles
[Yitao Wang]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Tianhong Yin]'s Articles
[Xiangjun Kong]'s Articles
[Yitao Wang]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.